(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.37%) $79.28
(-0.37%) $2.18
(-0.30%) $2 315.30
(-0.11%) $27.57
(0.35%) $988.00
(0.05%) $0.931
(0.11%) $10.90
(0.03%) $0.800
(0.00%) $91.74
2.48% HKD 10.74
Live Chart Being Loaded With Signals
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China...
Stats | |
---|---|
Dzisiejszy wolumen | 3 600.00 |
Średni wolumen | 176 362 |
Kapitalizacja rynkowa | 3.44B |
EPS | HKD0 ( 2023-08-29 ) |
Last Dividend | HKD0.479 ( 2023-07-04 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 7.73 |
ATR14 | HKD0.0360 (0.34%) |
China Isotope & Radiation Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
China Isotope & Radiation Finanse
Annual | 2022 |
Przychody: | HKD6.15B |
Zysk brutto: | HKD3.51B (57.18 %) |
EPS: | HKD1.220 |
FY | 2022 |
Przychody: | HKD6.15B |
Zysk brutto: | HKD3.51B (57.18 %) |
EPS: | HKD1.220 |
FY | 2021 |
Przychody: | HKD5.14B |
Zysk brutto: | HKD3.24B (63.03 %) |
EPS: | HKD1.050 |
FY | 2020 |
Przychody: | HKD4.27B |
Zysk brutto: | HKD2.62B (61.20 %) |
EPS: | HKD0.670 |
Financial Reports:
No articles found.
China Isotope & Radiation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.479 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.169 | 2018-11-28 |
Last Dividend | HKD0.479 | 2023-07-04 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 6 | -- |
Total Paid Out | HKD1.597 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.03 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.17 | |
Div. Directional Score | 8.22 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
2238.HK | Ex Dividend Junior | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
1257.HK | No Dividend Player | 2023-09-12 | Annually | 0 | 0.00% | |
0305.HK | Ex Dividend Junior | 2023-06-15 | Annually | 0 | 0.00% | |
6033.HK | Ex Dividend Knight | 2023-09-19 | Semi-Annually | 0 | 0.00% | |
1811.HK | Ex Dividend Junior | 2023-06-06 | Sporadic | 0 | 0.00% | |
0839.HK | Ex Dividend Knight | 2023-06-09 | Semi-Annually | 0 | 0.00% | |
2488.HK | Ex Dividend Junior | 2023-08-22 | Sporadic | 0 | 0.00% | |
1378.HK | Ex Dividend Knight | 2023-11-16 | Annually | 0 | 0.00% | |
0435.HK | Ex Dividend Knight | 2023-09-21 | Semi-Annually | 0 | 0.00% | |
6823.HK | Ex Dividend Knight | 2023-08-17 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0650 | 1.500 | 8.70 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0345 | 1.200 | 8.85 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0914 | 1.500 | -0.0960 | -0.144 | [0.1 - 1] |
payoutRatioTTM | 0.297 | -1.000 | 7.03 | -7.03 | [0 - 1] |
currentRatioTTM | 1.833 | 0.800 | 5.83 | 4.67 | [1 - 3] |
quickRatioTTM | 1.477 | 0.800 | 6.02 | 4.81 | [0.8 - 2.5] |
cashRatioTTM | 0.542 | 1.500 | 8.10 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0824 | -1.500 | 8.63 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.06 | 2.00 | 9.31 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0215 | 2.00 | 9.99 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.218 | -1.500 | 9.13 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.553 | 1.000 | 4.11 | 4.11 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.142 | 1.000 | 9.15 | 9.15 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.677 | 1.000 | 7.35 | 7.35 | [0.2 - 2] |
assetTurnoverTTM | 0.531 | 0.800 | 9.79 | 7.83 | [0.5 - 2] |
Total Score | 11.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 7.66 | 1.000 | 9.33 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0914 | 2.50 | -0.0617 | -0.144 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0215 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.91 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.06 | 2.00 | 9.31 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.297 | 1.500 | 7.03 | -7.03 | [0 - 1] |
pegRatioTTM | -0.237 | 1.500 | -4.91 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.105 | 1.000 | 9.88 | 0 | [0.1 - 0.5] |
Total Score | 5.17 |
China Isotope & Radiation
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Independent Clinical Medical and Laboratory Services, and Other Business. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; UBT kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment provides medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Independent Clinical Medical and Laboratory Services, and Other Business segment provides independent clinical laboratory services with respect to hepatitis, endocrine, bone metabolism, cardiovascular disease, diabetes, and other diseases to hospitals and other medical institutions. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej